Brendan Payne | Stern Investor Relations |
Geoff Green | Chief Executive Officer |
Joshua Hare | Co-Founder, Chief Science Officer and Chairman |
James Clavijo | Chief Financial Officer |
Greetings and welcome to Longeveron's call today to discuss the results of the company's Phase 2b Aging Frailty trial and Second Quarter 2021 Financial Results. All participants are currently in a listen-only mode.
Following the formal presentation, we will open the call up for question-and-answer session. [Operator Instructions] I'd now like to turn the call over to Brendan Payne from Stern IR. Brendan, you may proceed.